Infant Modified Constraint Induced Movement Therapy Paired With Neuromuscular Electrical Stimulation: a Case Series
Completed
Conditions studied: Hemiplegia, Cerebral Palsy, Unilateral Cerebral Palsy
In brief
This study will compare the motor outcomes for five infants with asymmetrical hand function (AHF) who will receive two, three week episodes of standard care separated by a three week episode of mCIMT paired with Neuromuscular Electrical Stimulation. The results of this study will inform decisions on the feasibility and efficacy of the treatment for use in a larger study for infants with AHF at risk for unilateral cerebral palsy.
Key facts
- Study ID
- NCT05134272
- Run by
- Kathy Grinde
- People needed
- 5
- Starts
- 2021-11-17
- Expected to finish
- 2023-05-31
- Last updated by the study team
- 2023-06-27
Who can join
Age: 1 and older, up to 1. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Infant is 7-10 months of age (CCA)
- Clinical presentation of asymmetrical hand function,
- Grade 2/5 movement in more impaired upper extremity,
- Demonstrate potential to participate in 6 hours of therapy/week during 3 week episode of mCIMT-NMES, as determined by principal investigator,
- Parent/guardian willing to be partners in study and participate in follow-up assessments until child is 18 months of age
You may not qualify if…
- Medical or sensory condition that prevents full therapy participation (active seizures, significant visual impairment)
- Received Botox injection to more impaired upper extremity within last 6 months,
- NMES contraindicated (impaired skin integrity, presence of pacemaker, clotting disorder),
- Previous UE surgery or nerve injury (brachial plexus)
Where it is running
- Children's Minnesota — Maple Grove, Minnesota, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.